O
6.62
0.03 (0.38%)
| Previous Close | 6.60 |
| Volume | 1,371,362 |
| Price / Sales | 27.09 |
| Price / Book | 2.78 |
| 52 Weeks Range |
| Operating Margin (TTM) | -597.47% |
| Diluted EPS (TTM) | -1.11 |
| Quarterly Revenue Growth (YOY) | -27.60% |
| Total Debt/Equity (MRQ) | 28.66% |
| Current Ratio (MRQ) | 10.22 |
| Operating Cash Flow (TTM) | -145.46 M |
| Levered Free Cash Flow (TTM) | -87.96 M |
| Return on Assets (TTM) | -27.21% |
| Return on Equity (TTM) | -57.19% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Ocular Therapeutix, Inc. | Mixed | Bullish |
AIStockmoo Score
| Value 35% | -0.1 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -0.1 |
| Timing 35% | -0.4 |
| AI Technical info | NA |
| Technical Oscillators info | -4.0 |
| Technical Moving Averages info | 5.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.21 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -21.3% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 3.1 |
| Final Score | -0.27 |
Select this tab to load the latest available analysis.
|
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 87.01% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |